Inventor · disambiguated record
Betty Lam
Also filed as: LAM BETTY
16 granted patents·11 pending applications·72 citations·filing 2005–2024
92Inventor score
Files withTAKEDA PHARMACEUTICALS CO10VIVIDION THERAPEUTICS INC6TAKEDA PHARMACEUTICAL4ARIKAWA YASUYOSHI2CALITHERA BIOSCIENCES INC2
Top patents by PatentIndex Score
27 records- 0192US9556130B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 31, 2017·9 cites·18 claims
- 0292US8440689B2Fused heteroaromatic pyrrolidinonesARIKAWA YASUYOSHI·Filed 2010·Granted May 14, 2013·23 cites·28 claims
- 0391US11173161B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·2 cites·33 claims
- 0491US10159677B24-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 25, 2018·7 cites·32 claims
- 0590US9770450B24-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·7 cites·32 claims
- 0687US10561662B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 18, 2020·4 cites·32 claims
- 0783US8318727B2Polo-like kinase inhibitorsCAO SHELDON X·Filed 2010·Granted Nov 27, 2012·13 cites·13 claims
- 0883US2023295171A1Fused heteroaromatic pyrrolidinonesCALITHERA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0978US9108970B2Fused heteroaromatic pyrrolidinonesTAKEDA PHARMACEUTICAL·Filed 2013·Granted Aug 18, 2015·2 cites·31 claims
- 1075US9181255B2Fused heteroaromatic pyrrolidinones as SYK inhibitorsARIKAWA YASUYOSHI·Filed 2010·Granted Nov 10, 2015·2 cites·28 claims
- 1171US7825242B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Nov 2, 2010·1 cites·15 claims
- 1271US2025188040A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1369US12187685B2Pharmaceutical compositions comprising WRN helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·23 claims
- 1469US2024067612A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1568US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 1668US2022306634A1Fused heteroaromatic pyrrolidinonesCALITHERA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1767US8133898B2Renin inhibitorsGWALTNEY STEPHEN L·Filed 2008·Granted Mar 13, 2012·1 cites·21 claims
- 1863US2018141951A1Fused heteroaromatic pyrrolidinonesTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 1961US2025332156A1Pharmaceutical compositions comprising wrn helicase inhibitorsVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2059US2024270705A1Compounds selective for jak1 and methods of useVIVIDION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2015336964A1Fused heteroaromatic pyrrolidinonesTAKEDA PHARMACEUTICAL·Filed 2015·Application pending·0 cites
- 2251US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 2350US2009291938A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 2449US12370192B2Azole-fused pyridazin-3(2H)-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 29, 2025·0 cites·28 claims
- 2549US2017327497A1Substituted 6-aza-isoindolin-1-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2645US8148367B2Renin inhibitorsKWOK LILY·Filed 2008·Granted Apr 3, 2012·0 cites·13 claims
- 2742US2023045737A1Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitmentVIVIDION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Betty Lam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →